Clinical Trial Update: Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating venetoclax in combination with SL-401 and chemotherapy for Blastic plasmacytoid dendritic cell neoplasm is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blastic Plasmacytoid Dendritic Cell Neoplasm

Drugs mentioned

• SL-401
• Venetoclax (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 2 | Status: RECRUITING